Detalhe da pesquisa
1.
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation.
Mol Psychiatry
; 27(4): 1990-1999, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35173266
2.
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits.
Alzheimers Dement
; 19(6): 2317-2331, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36464806
3.
Neuropsychiatric Symptoms in Dementia: Considering a Clinical Role for Electroencephalography.
J Neuropsychiatry Clin Neurosci
; 34(3): 214-223, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35306829
4.
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.
Alzheimers Dement
; 2022 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35698882
5.
Characteristics of subjective cognitive decline associated with amyloid positivity.
Alzheimers Dement
; 18(10): 1832-1845, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34877782
6.
Replication study of plasma proteins relating to Alzheimer's pathology.
Alzheimers Dement
; 17(9): 1452-1464, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792144
7.
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.
Alzheimers Dement
; 15(7): 888-898, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31164314
8.
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.
Alzheimers Dement
; 15(6): 742-753, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30967340
9.
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
Alzheimers Dement
; 15(5): 644-654, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30853464
10.
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
Alzheimers Dement
; 15(6): 817-827, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31078433
11.
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
Alzheimers Dement
; 15(11): 1478-1488, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31495601
12.
Prevalence of the apolipoprotein E ε4 allele in amyloid ß positive subjects across the spectrum of Alzheimer's disease.
Alzheimers Dement
; 14(7): 913-924, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29601787
13.
Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers.
Alzheimers Dement
; 13(8): 903-912, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28216393
14.
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
Brain
; 138(Pt 5): 1327-38, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25693589
15.
Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study.
J Lipid Res
; 56(3): 674-681, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25616438
16.
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
JAMA
; 313(19): 1924-38, 2015 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25988462
17.
Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
Am J Geriatr Psychiatry
; 22(4): 341-8, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24035407
18.
Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
Dement Geriatr Cogn Disord
; 38(3-4): 234-44, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24969380
19.
High Contrast PET Imaging of Subcortical and Allocortical Amyloid-ß in Early Alzheimer's Disease Using [11C]AZD2184.
J Alzheimers Dis
; 98(4): 1391-1401, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552111
20.
Low background and high contrast PET imaging of amyloid-ß with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients.
Eur J Nucl Med Mol Imaging
; 40(4): 580-93, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23324871